Publication | Open Access
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial
1.2K
Citations
23
References
2012
Year
Gastrointestinal OncologyMedicineRandomised Phase 3Colorectal CancerPathologyMetastatic Colorectal CancerCancer TreatmentFirst ProgressionOncologyRadiation Oncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1